This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood ...

A large genetic study shows that many people carry DNA sequences that slowly expand as they get older. Common genetic ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing treatment on the NHS. Ms Mehta, 36, from London, suffers from beta thalassaemia, a ...

Abstract: In medical diagnostics, the reliable detection of blood disorders is critical for improving patient care and ensuring optimal treatment outcomes. Blood clotting is a vital physiological ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

A groundbreaking oral treatment for thalassemia, Mitapivat, has received US FDA approval, offering hope for adults with this ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

King Faisal Specialist Hospital & Research Centre continues to advance pediatric care through specialized programs dedicated to solid tumors and non-malignant blood disorders, supported by ...

Explore specialized training for nurse practitioners in hematology, aiding advanced cancer care and addressing patient needs.

These authors contributed equally to this work. Major depressive disorder (MDD) is a leading cause of disability, with a twofold increase in prevalence in women compared to men. Over the last few ...